Literature DB >> 16267254

Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction.

Nikolay Vasilyev1, Timothy Williams, Marie-Luise Brennan, Samuel Unzek, Xiaorong Zhou, Jay W Heinecke, Douglas R Spitz, Eric J Topol, Stanley L Hazen, Marc S Penn.   

Abstract

BACKGROUND: Inflammation after myocardial infarction (MI) heralds worse left ventricular (LV) function and clinical outcomes. However, whether inflammation affects LV function by extending myonecrosis and/or altering LV remodeling remains unknown. We hypothesized that cytotoxic aldehydes generated during oxidative stress may adversely affect remodeling and infarct size. One theoretical source of reactive aldehydes is oxidation of common alpha-amino acids by myeloperoxidase (MPO) released by leukocytes. However, a role for MPO in formation of aldehydes in vivo and the functional consequences of MPO-generated oxidants in ischemia/reperfusion models of MI have not been established. METHODS AND
RESULTS: In studies with cell types found in vascular tissue, MPO-oxidation products of glycine (formaldehyde) and threonine (acrolein) were the most cytotoxic. Mass spectrometry studies of myocardial tissue from murine models of acute MI (both chronic left anterior descending coronary artery ligation and ischemia/reperfusion injury) confirmed that MPO serves as a major enzymatic source in the generation of these cytotoxic aldehydes. Interestingly, although MPO-null mice experienced 35.1% (P<0.001) less LV dilation and a 52.2% (P<0.0001) improvement in LV function compared with wild-type mice 24 days after ischemia/reperfusion injury, no difference in infarct size between wild-type and MPO-null mice was noted.
CONCLUSIONS: The present data separate inflammatory effects on infarct size and LV remodeling and demonstrate that MPO-generated oxidants do not significantly affect tissue necrosis after MI but rather have a profound adverse effect on LV remodeling and function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267254     DOI: 10.1161/CIRCULATIONAHA.105.542340

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  64 in total

1.  Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular Remodeling.

Authors:  Martin Mollenhauer; Kai Friedrichs; Max Lange; Jan Gesenberg; Lisa Remane; Christina Kerkenpaß; Jenny Krause; Johanna Schneider; Thorben Ravekes; Martina Maass; Marcel Halbach; Gabriel Peinkofer; Tomo Saric; Dennis Mehrkens; Matti Adam; Florian G Deuschl; Denise Lau; Birgit Geertz; Kashish Manchanda; Thomas Eschenhagen; Lukas Kubala; Tanja K Rudolph; Yuping Wu; W H Wilson Tang; Stanley L Hazen; Stephan Baldus; Anna Klinke; Volker Rudolph
Journal:  Circ Res       Date:  2017-04-12       Impact factor: 17.367

2.  Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice.

Authors:  Shahid P Baba; Deqing Zhang; Mahavir Singh; Sujith Dassanayaka; Zhengzhi Xie; Ganapathy Jagatheesan; Jingjing Zhao; Virginia K Schmidtke; Kenneth R Brittian; Michael L Merchant; Daniel J Conklin; Steven P Jones; Aruni Bhatnagar
Journal:  J Mol Cell Cardiol       Date:  2018-04-05       Impact factor: 5.000

3.  Evaluation of serum myeloperoxidase concentration in dogs with heart failure due to chronic mitral valvular insufficiency.

Authors:  Jong-In Park; Sang-Il Suh; Changbaig Hyun
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

4.  Acute myocardial infarction in rats.

Authors:  Yewen Wu; Xing Yin; Cori Wijaya; Ming-He Huang; Bradley K McConnell
Journal:  J Vis Exp       Date:  2011-02-16       Impact factor: 1.355

5.  Apolipoprotein A1 regulates coenzyme Q10 absorption, mitochondrial function, and infarct size in a mouse model of myocardial infarction.

Authors:  Alisher R Dadabayev; Guotian Yin; Calivarathan Latchoumycandane; Thomas M McIntyre; Edward J Lesnefsky; Marc S Penn
Journal:  J Nutr       Date:  2014-04-23       Impact factor: 4.798

Review 6.  Regulation of signal transduction by reactive oxygen species in the cardiovascular system.

Authors:  David I Brown; Kathy K Griendling
Journal:  Circ Res       Date:  2015-01-30       Impact factor: 17.367

7.  Endothelial dysfunction and claudin 5 regulation during acrolein-induced lung injury.

Authors:  An Soo Jang; Vincent J Concel; Kiflai Bein; Kelly A Brant; Shannen Liu; Hannah Pope-Varsalona; Richard A Dopico; Y P Peter Di; Daren L Knoell; Aaron Barchowsky; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-04       Impact factor: 6.914

8.  Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a.

Authors:  Timothy E O'Toole; Wesley Abplanalp; Xiaohong Li; Nigel Cooper; Daniel J Conklin; Petra Haberzettl; Aruni Bhatnagar
Journal:  Toxicol Sci       Date:  2014-05-08       Impact factor: 4.849

Review 9.  Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease.

Authors:  Jan F Stevens; Claudia S Maier
Journal:  Mol Nutr Food Res       Date:  2008-01       Impact factor: 5.914

Review 10.  Recent advances in cardiovascular proteomics.

Authors:  Parveen Sharma; Jake Cosme; Anthony O Gramolini
Journal:  J Proteomics       Date:  2012-11-12       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.